![[Internal] Newsroom thumbnail Inflammasome Therapeutics Reports 3 Month Trial Data for Its Dual Inflammasome Inhibitor in Geographic Atrophy](https://piemagazine.org/wp-content/uploads/sites/4/2025/01/Internal-Newsroom-thumbnail-Inflammasome-Therapeutics-Reports-3-Month-Trial-Data-for-Its-Dual-Inflammasome-Inhibitor-in-Geographic-Atrophy-1182x540.png)
Inflammasome Therapeutics Reports 3-Month Trial Data for Inflammasome Inhibitor in Geographic Atrophy
Inflammasome Therapeutics Reports Topline 3-Month Trial Data for Novel Geographic Atrophy Treatment The findings revealed a significant reduction in lesion…
Inflammasome Therapeutics Reports Topline 3-Month Trial Data for Novel Geographic Atrophy Treatment The findings revealed a significant reduction in lesion…
![[Topcon] 2024 Recap Thumbnail Topcon Healthcare 2024 Recap (1)](https://piemagazine.org/wp-content/uploads/sites/4/2025/01/Topcon-2024-Recap-Thumbnail-Topcon-Healthcare-2024-Recap-1-579x326.png)
![[Topcon] APGC KOL interview Dr. Ho Ching Lin thumbnail MicroPulse Transscleral Cyclophotocoagulation with the Cyclo G6 Laser (1)](https://piemagazine.org/wp-content/uploads/sites/4/2025/01/Topcon-APGC-KOL-interview-Dr.-Ho-Ching-Lin-thumbnail-MicroPulse-Transscleral-Cyclophotocoagulation-with-the-Cyclo-G6-Laser-1-579x326.png)
![[Topcon] Presentation _1 Prof. Giannaccare thumbnail Shedding Light on Dry AMD with eye light® LM® LLLT (1) (1)](https://piemagazine.org/wp-content/uploads/sites/4/2025/01/Topcon-Presentation-_1-Prof.-Giannaccare-thumbnail-Shedding-Light-on-Dry-AMD-with-eye-light®-LM®-LLLT-1-1-579x326.png)
![[Internal] Newsroom thumbnail Inflammasome Therapeutics Reports 3 Month Trial Data for Its Dual Inflammasome Inhibitor in Geographic Atrophy](https://piemagazine.org/wp-content/uploads/sites/4/2025/01/Internal-Newsroom-thumbnail-Inflammasome-Therapeutics-Reports-3-Month-Trial-Data-for-Its-Dual-Inflammasome-Inhibitor-in-Geographic-Atrophy-579x326.png)
